Driving Growth: Key Factors Shaping the High-performance Liquid Chromatography (HPLC) Market

The growth in high-performance liquid chromatography market is driven by high sensitivity &accuracy of the HPLC technique, the growing importance of HPLC tests in drug approvals, the rising popularity of hyphenated techniques, and increasing pharmaceutical R&D spending. However, the high cost of HPLC systems is expected to restrict market growth to a certain extent.

The global high-performance liquid chromatography market size is projected to reach USD 5.7 billion by 2025 from USD 4.5 billion in 2020, at a CAGR of 4.6% during the forecast period.

Download PDF Brochure: – https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=117899209


           1 DRIVERS
                   1.1 High sensitivity and accuracy of the HPLC technique
                   1.2 Growing popularity of hyphenated techniques
                   1.3 Growing importance of HPLC tests in drug approvals
                   1.4 Increasing pharmaceutical R&D spending

          2 RESTRAINTS
                   2.1 High cost of equipment
                   2.2 Dearth of skilled professionals

                   3.1 Increasing use of chromatography in the purification of monoclonal antibodies
                   3.2 Emerging markets in the Asia Pacific region

          4 CHALLENGES
                   4.1 Extensive requirements in developing systems that generate pressure above 20,000 psi
                   4.2 Lack of long-term reproducibility

Market Segmentation: –

Based on the product, the market was divided into instruments, consumables, and accessories. The instrument market is subjected to account for the largest share in the HPLC market and consumables to growth at the highest rate during the forecast period.

Based on the application, the HPLC market is divided into clinical research, diagnostics, forensics, and other applications. Clinical research is subjected to grow at the highest rate in the forecast period. A rise in pharmaceutical and biotechnological research fueled by the need for numerous preclinical and clinical studies performed during the drug discovery and development process is said to drive the market.

Regional Analysis:

North America is expected to account for the largest share of the global HPLC market. Market growth in this region is driven primarily by the increase in R&D funding, the growing number of preclinical activities by CROs &pharmaceutical companies, and the increasing food & agricultural industry in Canada.

Get 10% Customization on this Research Report: – https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=117899209

Top key Players:

The global HPLC market is well established owing to the dominance of prominent market players, such as Waters (US), Agilent (US), Shimadzu (Japan), Thermo Fisher (US), PerkinElmer (US), GE Healthcare (US), Bio-Rad (US), Merck Millipore (Germany), Hitachi (Japan), Showa Denko (Japan), Gilson (US), Phenomenex (US), JASCO (US), Hamilton Company (US), SIELC (US), Orochem (US), YMC Co. Ltd. (Japan), Restek (US), Trajan Scientific (Australia), and Tosoh Bioscience LLC (Japan).

In conclusion, the High-performance Liquid Chromatography (HPLC) market continues to grow due to its widespread applications across multiple industries, technological advancements, regulatory requirements, and the increasing need for accurate and reliable analytical methods.